Investigation of nano lipid vesicles of methotrexate for anti-rheumatoid activity
Prabhakara Prabhu1, Rakshith Shetty1, Marina Koland1, K Vijayanarayana3, KK Vijayalakshmi2, M Harish Nairy1, GS Nisha11Department of Pharmaceutics, Nitte University, NGSM Institute of Pharmaceutical Sciences, Paneer, Deralakatte, Mangalore, Karnataka, India; 2Department of Applied Zoology, Mangalore...
Guardado en:
Autores principales: | Prabhu P, Shetty R, Kol, M, Vijayanarayana K, Vijayalakshmi KK, Nairy MH, Nisha GS |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e3c89564fac24722831229dcac29848d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prediction of response of methotrexate in patients with rheumatoid arthritis using serum lipidomics
por: Mateusz Maciejewski, et al.
Publicado: (2021) -
Construction of a Nano-Controlled Release Methotrexate Delivery System for the Treatment of Rheumatoid Arthritis by Local Percutaneous Administration
por: Tingting Guo, et al.
Publicado: (2021) -
Effects of low-dose tacrolimus therapy in combination with methotrexate in patients with methotrexate-refractory rheumatoid arthritis
por: Takeo Isozaki, et al.
Publicado: (2010) -
Recommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis
por: Bello AE, et al.
Publicado: (2017) -
Risk Factors Associated with Methotrexate Intolerance in Rheumatoid Arthritis Patients
por: Almalag H, et al.
Publicado: (2020)